Related Experiment Video
Updated: May 28, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
Published on: July 7, 2023
Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor
Mark H Rapaport1, Rachel E Maddux
1Department of Psychiatry, Cedars-Sinai Medical Center, Los Angeles, Calif, USA; Department of Psychiatry, University of California, Los Angeles, Los Angeles, Calif, USA.
Abstract:
This paper reviews some of the challenges faced by individuals who design and implement clinical trials of potential antidepressant medications. Particular emphasis is placed on questioning the validity of some of the theoretical assumptions that form the underpinnings of most conventional trials. Work from our group developing clinical trial methodology for minor depression is used as an example of how alternate constructs may be helpful to differentiate drug-placebo differences.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Clinical Trials: Overview
Antidepressant Drugs: MAOIs and Other Agents
Clinical Trials
There are four phases in a clinical trial. A phase one...

